Surgery Partners (NASDAQ:SGRY) Shares Gap Up to $25.60

Shares of Surgery Partners, Inc. (NASDAQ:SGRY - Get Free Report) gapped up prior to trading on Tuesday . The stock had previously closed at $25.60, but opened at $27.50. Surgery Partners shares last traded at $27.20, with a volume of 438,583 shares traded.

Analysts Set New Price Targets

SGRY has been the subject of a number of recent analyst reports. Benchmark reissued a "buy" rating and set a $50.00 target price on shares of Surgery Partners in a research note on Wednesday, May 1st. StockNews.com raised shares of Surgery Partners from a "sell" rating to a "hold" rating in a research note on Thursday, March 21st. Citigroup dropped their price objective on Surgery Partners from $43.00 to $42.00 and set a "buy" rating on the stock in a research note on Tuesday, February 27th. Barclays assumed coverage on Surgery Partners in a research report on Wednesday, March 6th. They set an "equal weight" rating and a $35.00 target price for the company. Finally, Cantor Fitzgerald reissued an "overweight" rating and set a $43.00 price target on shares of Surgery Partners in a research report on Wednesday, April 10th. Two analysts have rated the stock with a hold rating and seven have issued a buy rating to the company. According to MarketBeat, the company has an average rating of "Moderate Buy" and an average price target of $43.63.

Surgery Partners Stock Up 8.5 %

The company has a debt-to-equity ratio of 0.89, a quick ratio of 1.57 and a current ratio of 1.71. The firm has a market capitalization of $3.53 billion, a P/E ratio of -283.50, a PEG ratio of 2.24 and a beta of 2.75. The business's fifty day moving average price is $27.54 and its two-hundred day moving average price is $29.79.

Surgery Partners (NASDAQ:SGRY - Get Free Report) last released its quarterly earnings results on Monday, February 26th. The company reported $0.44 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.37 by $0.07. The business had revenue of $735.40 million for the quarter, compared to analyst estimates of $741.93 million. Surgery Partners had a negative net margin of 0.43% and a positive return on equity of 3.65%. The business's revenue for the quarter was up 4.0% on a year-over-year basis. During the same period in the previous year, the company earned $0.22 earnings per share. Equities analysts expect that Surgery Partners, Inc. will post 0.78 earnings per share for the current fiscal year.

Insiders Place Their Bets

In other news, insider Bradley R. Owens sold 1,040 shares of the company's stock in a transaction dated Monday, February 12th. The shares were sold at an average price of $35.22, for a total transaction of $36,628.80. Following the transaction, the insider now owns 73,149 shares in the company, valued at $2,576,307.78. The transaction was disclosed in a filing with the SEC, which is accessible through this hyperlink. In other Surgery Partners news, CEO Jason Eric Evans sold 5,780 shares of Surgery Partners stock in a transaction dated Monday, February 12th. The stock was sold at an average price of $35.08, for a total transaction of $202,762.40. Following the completion of the sale, the chief executive officer now owns 419,118 shares of the company's stock, valued at approximately $14,702,659.44. The sale was disclosed in a legal filing with the SEC, which is accessible through this hyperlink. Also, insider Bradley R. Owens sold 1,040 shares of the stock in a transaction dated Monday, February 12th. The shares were sold at an average price of $35.22, for a total value of $36,628.80. Following the completion of the transaction, the insider now directly owns 73,149 shares in the company, valued at $2,576,307.78. The disclosure for this sale can be found here. Over the last 90 days, insiders sold 14,664 shares of company stock valued at $477,225. 2.60% of the stock is currently owned by corporate insiders.

Hedge Funds Weigh In On Surgery Partners

Several hedge funds and other institutional investors have recently bought and sold shares of the business. DekaBank Deutsche Girozentrale acquired a new stake in Surgery Partners during the third quarter worth about $39,000. Strs Ohio acquired a new stake in shares of Surgery Partners during the 4th quarter worth approximately $51,000. Signaturefd LLC purchased a new position in shares of Surgery Partners during the 3rd quarter valued at approximately $56,000. Nisa Investment Advisors LLC lifted its stake in shares of Surgery Partners by 69.7% in the 3rd quarter. Nisa Investment Advisors LLC now owns 2,945 shares of the company's stock valued at $86,000 after purchasing an additional 1,210 shares during the period. Finally, Mesirow Institutional Investment Management Inc. boosted its holdings in Surgery Partners by 12.4% during the fourth quarter. Mesirow Institutional Investment Management Inc. now owns 3,388 shares of the company's stock worth $108,000 after buying an additional 373 shares in the last quarter.

Surgery Partners Company Profile

Surgery Partners, Inc, together with its subsidiaries, owns and operates a network of surgical facilities and ancillary services in the United States. The company provides ambulatory surgery centers and surgical hospitals that offer non-emergency surgical procedures in various specialties, including orthopedics and pain management, ophthalmology, gastroenterology, and general surgery.